For the year ending 2025-12-31, GNPX has $10,159,011 in assets. $2,197,135 in debts. $7,830,855 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 7,830,855 | |||
| Prepaid expenses and other | 525,928 | |||
| Total current assets | 8,356,783 | |||
| Property and equipment, net | 0 | |||
| Research and development supplies | 1,802,228 | |||
| Total non-current assets | 1,802,228 | |||
| Total assets | 10,159,011 | |||
| Accounts payables | 743,070 | |||
| Other current liabilities | 1,431,565 | |||
| Total current liabilities | 2,174,635 | |||
| Derivative liabilities | 22,500 | |||
| Total liabilities | 2,197,135 | |||
| Common stock 0.001 par value 200,000,000 shares authorized 3,291,488 and 217,234 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 3,291 | |||
| Additional paid-in capital | 178,986,981 | |||
| Accumulated deficit | -171,028,396 | |||
| Total stockholders' equity | 7,961,876 | |||
| Total liabilities and stockholders' equity | 10,159,011 | |||
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)